Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Etoposide
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Etoposide 100mg capsules
0801040D0AAABAB
|
Etoposide | Etoposide | Malignant Disease and Immunosuppression | No data available |
|
Etoposide 100mg powder for solution for injection vials
0801040D0AAAGAG
|
Etoposide | Etoposide | Malignant Disease and Immunosuppression | No data available |
|
Etoposide 100mg/5ml solution for infusion vials
0801040D0AAADAD
|
Etoposide | Etoposide | Malignant Disease and Immunosuppression | No data available |
|
Etoposide 200mg/10ml solution for infusion vials
0801040D0AAAEAE
|
Etoposide | Etoposide | Malignant Disease and Immunosuppression | No data available |
|
Etoposide 500mg/25ml solution for infusion vials
0801040D0AAAFAF
|
Etoposide | Etoposide | Malignant Disease and Immunosuppression | No data available |
|
Etoposide 50mg capsules
0801040D0AAAAAA
|
Etoposide | Etoposide | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.